1Maron BJ, Towbin J A, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an AHA scientific statement from the council on clinical cardiology, HF and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation, 2006,113(14) : 1807-1816. 被引量：1
3Jane-Wit D, Altuntas CZ, Johnson JM, et al. Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyle apoptosis. Circulation, 2007,116(4) : 399-410. 被引量：1
4Liao YH, Yuan J, Wang ZH, et al. Infectious tolerance to ADP/ATP carrier peptides induced by anti-L3T4 monoclonal antibody in dilated cardiomyopathy mice. J Clin Immunol, 2005, 25(4): 376-384. 被引量：1
5Baba A, Yoshikawa T, Fukuda Y, et al. Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J, 2004,25:1108-1115. 被引量：1
6Mobini R, Staudt A, Felix SB, et al. Hemodynamic improvement and removal of autoantibodies against betal-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun, 2003, 20:345-350. 被引量：1
7Dorffela WV, Wallukat G, Dorffel Y, et al. Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up. Int J Cardiol, 2004,97: 529-534. 被引量：1
8Knebel F, Bohm M, Staudt A, et al. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy. Int J Cardiol, 2004,97:517-520. 被引量：1
9I.iu W , Li WM, Yang SS, et al. Association of HLA class Ⅱ DRB1, DPA1 and DPB1 polymorphism with genetic suscepti bility to idiopathic dilated cardiomyopathy in Chinese Hanna tionality. Autoimmunity, 2006,39(6): 461-467. 被引量：1
10Hailer K, Kisand PR, Fragoso JM, et al. MHC class Ⅱ genes in Mexican patients with idiopathic dilated cardiomyopathy. Exp Mol Path, 2007,82:49-52. 被引量：1
2BradyWJ, Fergusen JD, Ullman EA, el al. Myocarditis: emergency department recognition and management[J]. Emerg Med Clin North Am, 2004,22(4):865 - 885. 被引量：1
3Burkett EL, Hershberger RE.Clinical and genetic issues in familial dilated cardiomyopathy[J] .J Am Coll Cardiol,2005,45:969 - 981. 被引量：1
4Liao YH. Functional analysis of autoantibodies against ADP/ATPcarrier from dilated cardiomyopathy[J]. Int J Cardiol, 1996, 54: 165 - 169. 被引量：1
